Nortech Systems grants director 8,000 stock options
NSYS director Ryan McManus received 8,000 stock options at a $12.19 strike, lifting his direct common stock holdings to 14,857 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NORTECH SYSTEMS INC (NSYS) director Ryan McManus reported an award of 8,000 Stock Options on March 31, 2026. The options have an exercise price of $12.19 per share, become exercisable on May 1, 2027, and expire on March 31, 2036. After this grant, he holds 14,857 shares of Common Stock directly, including previously granted Restricted Stock Units. No transactions are reported under a Rule 10b5-1 trading plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options F2 | 8,000 | $0.00 | $0.00 |
| Holding | Common Stock F1 | -- | -- | -- |
Footnotes (2)
- F1. Includes 3,438 Restricted Stock Units granted on May 20, 2025, with 3,438 units vesting on May 1, 2027.
- F2. Represents 8,000 Stock Options granted on March 31, 2026, with 8,000 options exercisable on May 1, 2027.
Key Figures
Key Terms
Stock Options financial
Restricted Stock Units financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NSYS director Ryan McManus report on this Form 4?
What are the key terms of the 8,000 stock options reported for NSYS?
Are the NSYS transactions by Ryan McManus under a Rule 10b5-1 trading plan?
When do the newly granted NSYS options to Ryan McManus become exercisable?
AI-generated analysis. How Rhea-AI works. Not financial advice.